FOXP3+ Treg cells have been found to be significantly elevated in peripheral blood as well as tumor tissues, and upregulated infiltration predicted poor prognosis in a variety of cancers, including breast cancer, melanoma, non-small cell lung cancer, and gastric cancer [50,51]. This evidence concerns the gene FOXP3 and melanoma.